Previous What is the UK DRI? New scientific discoveries, new hope to stop dementia OUR PLANS Next 1 2 3 Research Study suggests new approaches may be needed for treating the later stages of Alzheimer’s disease A team of Cambridge researchers led by UK DRI Group Leader Prof Sir David Klenerman has shown that the accumulation of toxic brain proteins in the mid-late stages of Alzheimer’s, is driven by local replication of the proteins rather than by their spreading between brain regions. The important findings suggest that the disease mechanisms that should be therapeutically targeted may differ at each stage of the disease. READ MORE Government Spending Review: support for innovation, but missing the promised Dementia Moonshot The Chancellor did however use his speech to champion innovation in the UK, and announced a series of measures to boost R&D, including more funding for core science and initiatives to attract research talent from overseas. READ MORE Research partners Building connections across the dementia ecosystem The Dementia UK Ecosystem (DUKE) brings together leaders from the UK DRI, Dementias Platform UK, the National Institute for Health Research, the pharmaceutical industry, and funders to create a cohesive community, coordinating efforts to accelerate progress in tackling dementia. READ MORE Government “Fuelling the Moonshot”: MPs call for ten years of UK DRI funding Produced by a cross-party group of MPs and Peers in collaboration with Alzheimer’s Society, the 'Fuelling the Moonshot' report is the culmination of a detailed inquiry run by the All-Party Parliamentary Group (APPG) on Dementia, which received evidence from experts and organisations in the field of dementia research. The report makes a case for how the Government’s promised ‘Dementia Moonshot’ funding should be spent to best support research into dementia and neurodegeneration. READ MORE Awards Next generation sequencing pioneers awarded prestigious Breakthrough Prize in Life Sciences Prof Sir David Klenerman, UK DRI Group Leader at Cambridge, and Prof Sir Shankar Balasubramanian have been awarded the 2022 Breakthrough Prize for their development of Next Generation Sequencing. The groundbreaking technology significantly reduced the time and cost associated with sequencing a human genome, revolutionising modern research and medicine. READ MORE Keep in touch with UK DRI activities Sign up to our monthly e-newsletter - 'Inside Eye on UK DRI' SUBSCRIBE Science Vision Our priorities as a research institute We accelerate, innovate, deepen and broaden discovery science in dementia, with the goal of filling the huge knowledge gap in this field. We exist to bring forward the day when research benefits people living with and those at risk of dementia. READ OUR SCIENCE VISION Translation and innovation Turning breakthroughs into treatments We have a clearly defined vision at the UK DRI to develop effective therapeutics, diagnostics and technologies for people living with dementia. Alongside building our disease knowledge over the coming years, we will also make progress in translating these discoveries into the clinic. TRANSLATION AND INNOVATION Research themes Bringing together researchers to address major scientific questions We study a range of neurodegenerative disorders that cause dementia. Many of them share fundamental disease mechanisms and characteristics, and greater understanding gained in one can often benefit others. To ensure we capitalise on diverse expertise, approaches and perspectives, we have established cross-centre themes. RESEARCH THEMES Equity, Diversity and Inclusion Collaboration and connection Our efforts to increase the diversity of our team, ensure inclusion and promote equality of opportunity, align with our vision for the UK DRI’s Institute culture and identity as a world-leader in dementia research. EQUITY, DIVERSITY AND INCLUSION Founding funders Latest tweets from @UKDRI Get involved in #dementia research! 🧠 A team from UK DRI at Imperial, led by @nir_grossman, are recruiting volunte… https://t.co/GWSvwsKB6L 26 Nov 2021 17:00 Reply Retweet Favourite RT @CamNeuro: 📢Join us for the last @CamNeuro of the year on Tue 30th Nov, when we welcome Prof Giovanna Mallucci @MallucciLab @UKDRI ▶️'… 26 Nov 2021 15:17 Reply Retweet Favourite Address UK Dementia Research Institute HQ 6th Floor, UCL Maple House Tottenham Court Road London W1T 7NF UK DRI Ltd. Company No. 11045257 | Charity No. 1179589 Terms and conditions Privacy, data and cookies To donate Sitemap Contact Newsletter UK DRI Portal Social Twitter LinkedIn © 2021 UK Dementia Research Institute